David Michael Kranz
Affiliations: | University of Illinois, Urbana-Champaign, Urbana-Champaign, IL |
Area:
Immunology, BiochemistryWebsite:
https://mcb.illinois.edu/faculty/profile/d-kranz/Google:
"David Michael Kranz"Bio:
https://mcb.illinois.edu/news/feature/115/
Mean distance: (not calculated yet)
Parents
Sign in to add mentorEdward W. Voss | grad student | 1982 | UIUC | |
(Structure, function, and diversity of monoclonal anti-fluorescyl antibodies.) |
Children
Sign in to add traineeMichele C. Kieke | grad student | 2001 | UIUC |
Phillip D. Holler | grad student | 2002 | UIUC |
Peter Lee | grad student | 2002 | UIUC |
Susan E. Brophy | grad student | 2004 | UIUC |
Lukasz K. Chlewicki | grad student | 2004 | UIUC |
K. S. Weber | grad student | 2005 | UIUC |
Rebecca A. Buonpane | grad student | 2006 | UIUC |
Hywyn R. Churchill | grad student | 2006 | UIUC |
Sarah A. Richman | grad student | 2007 | UIUC |
Lindsay L. Jones | grad student | 2008 | UIUC |
Natalie A. Bowerman | grad student | 2009 | UIUC |
Adam S. Chervin | grad student | 2009 | UIUC |
David H. Aggen | grad student | 2010 | UIUC |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ranoa DRE, Sharma P, Schane CP, et al. (2023) Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model. Journal For Immunotherapy of Cancer. 11 |
Schaettler MO, Desai R, Wang AZ, et al. (2023) TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma. Journal For Immunotherapy of Cancer. 11 |
Singh NK, Alonso JA, Harris DT, et al. (2020) An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes. Biochemistry |
Chan KK, Dorosky D, Sharma P, et al. (2020) Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science (New York, N.Y.) |
Sharma P, Marada VVVR, Cai Q, et al. (2020) Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides. Proceedings of the National Academy of Sciences of the United States of America |
Baker B, Kranz D. (2020) Decision letter: Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity Elife |
Sharma P, Marada VV, Kizerwetter M, et al. (2020) Abstract 3238: Engineering chimeric antigen receptors for adoptive T cell therapy of cancers that express the Tn antigen Immunology |
Sharma P, Kranz DM. (2019) T Cell Receptors for Gene Transfer in Adoptive T Cell Therapy. Critical Reviews in Immunology. 39: 105-122 |
He Y, Schreiber K, Wolf SP, et al. (2019) Multiple cancer-specific antigens are targeted by a chimeric antibody receptor on a single cancer cell. Jci Insight. 4 |
Sharma P, Harris DT, Stone JD, et al. (2019) T-cell receptors engineered de novo for peptide specificity can mediate optimal T-cell activity without self cross-reactivity. Cancer Immunology Research |